US 10865236
Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
granted A61KA61K2039/505A61K2039/572
Quick answer
US patent 10865236 (Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/572, A61K39/40, A61P